Isenman DE - Search Results

1

Ig-like transcript 4 as a cellular receptor for soluble complement fragment C4d.

Hofer J, Forster F, Isenman DE, Wahrmann M, Leitner J, Hölzl MA, Kovarik JJ, Stockinger H, Böhmig GA, Steinberger P, Zlabinger GJ. Hofer J, et al. Among authors: isenman de. FASEB J. 2016 Apr;30(4):1492-503. doi: 10.1096/fj.15-275594. Epub 2015 Dec 17. FASEB J. 2016. PMID: 26678451

2

Neuropilin-1 Acts as a Receptor for Complement Split Products.

Battin C, De Sousa Linhares A, Paster W, Isenman DE, Wahrmann M, Leitner J, Zlabinger GJ, Steinberger P, Hofer J. Battin C, et al. Among authors: isenman de. Front Immunol. 2019 Sep 13;10:2209. doi: 10.3389/fimmu.2019.02209. eCollection 2019. Front Immunol. 2019. PMID: 31572401 Free PMC article.

3

X-ray crystal structure of the C4d fragment of human complement component C4.

van den Elsen JM, Martin A, Wong V, Clemenza L, Rose DR, Isenman DE. van den Elsen JM, et al. Among authors: isenman de. J Mol Biol. 2002 Oct 4;322(5):1103-15. doi: 10.1016/s0022-2836(02)00854-9. J Mol Biol. 2002. PMID: 12367531

4

Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21).

Clemenza L, Isenman DE. Clemenza L, et al. Among authors: isenman de. J Immunol. 2000 Oct 1;165(7):3839-48. doi: 10.4049/jimmunol.165.7.3839. J Immunol. 2000. PMID: 11034390

5

The C4A and C4B isotypic forms of human complement fragment C4b have the same intrinsic affinity for complement receptor 1 (CR1/CD35).

Clemenza L, Isenman DE. Clemenza L, et al. Among authors: isenman de. J Immunol. 2004 Feb 1;172(3):1670-80. doi: 10.4049/jimmunol.172.3.1670. J Immunol. 2004. PMID: 14734749

6

X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2.

Nagar B, Jones RG, Diefenbach RJ, Isenman DE, Rini JM. Nagar B, et al. Among authors: isenman de. Science. 1998 May 22;280(5367):1277-81. doi: 10.1126/science.280.5367.1277. Science. 1998. PMID: 9596584

7

Mutation of residues in the C3dg region of human complement component C3 corresponding to a proposed binding site for complement receptor type 2 (CR2, CD21) does not abolish binding of iC3b or C3dg to CR2.

Diefenbach RJ, Isenman DE. Diefenbach RJ, et al. Among authors: isenman de. J Immunol. 1995 Mar 1;154(5):2303-20. J Immunol. 1995. PMID: 7868901

8

Mutational analyses reveal that the staphylococcal immune evasion molecule Sbi and complement receptor 2 (CR2) share overlapping contact residues on C3d: implications for the controversy regarding the CR2/C3d cocrystal structure.

Isenman DE, Leung E, Mackay JD, Bagby S, van den Elsen JM. Isenman DE, et al. J Immunol. 2010 Feb 15;184(4):1946-55. doi: 10.4049/jimmunol.0902919. Epub 2010 Jan 18. J Immunol. 2010. PMID: 20083651

9

Interactions of human complement component C3 with factor B and with complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) involve an acidic sequence at the N-terminus of C3 alpha'-chain.

Taniguchi-Sidle A, Isenman DE. Taniguchi-Sidle A, et al. Among authors: isenman de. J Immunol. 1994 Dec 1;153(11):5285-302. J Immunol. 1994. PMID: 7963581

10

Mutagenesis of the Arg-Gly-Asp triplet in human complement component C3 does not abolish binding of iC3b to the leukocyte integrin complement receptor type III (CR3, CD11b/CD18).

Taniguchi-Sidle A, Isenman DE. Taniguchi-Sidle A, et al. Among authors: isenman de. J Biol Chem. 1992 Jan 5;267(1):635-43. J Biol Chem. 1992. PMID: 1730624 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page